Antidepressant Manufacturers’ Trial Information Requested By Senate Cmte.
This article was originally published in The Pink Sheet Daily
Executive Summary
Finance Chairman Grassley asks eight manufacturers for list of all pediatric antidepressant trials, including completion, publication and FDA submission information. Grassley expresses concern that the firms may not have provided FDA with all the information “at their disposal.”